Meg Gonsalves
Project Manager
Aligning Clinical Trials with Real-World Aging Trends
research spotlights
Eric Storms
Director of Business Development
Accelerating FDA Approval with MIDD: How A2-Ai Secured a New Dose Without a Phase 3 Trial
servicescase studies
Eric Storms
Director of Business Development
Introducing reportifyr: an R-Based Open-Source Tool for Automated Reporting
tooling
Simonne Bruck
Business Manager
MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies
news
Simonne Bruck
Business Manager
NCA Services - Here to Help You Make Informed, Data-Driven Decisions Quickly and Accurately in Real-Time
services
Simonne Bruck
Business Manager
A2-Ai Cloud - A Cloud-Based Platform for Drug Development, Your Way
productsservices
Simonne Bruck
Business Manager
IND Services - We Support and Assist You in IND Applications to Streamline the FDA Approval Process
services